Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined with Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial
Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined with Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial
Shiwei Zhang, Yuxiang Yin, Wenjie Zhu, Ning Jiang et al.
Journal
The Journal of Urology
Topics
Bladder and Urothelial Cancer Treatments
article
Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined with Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial
Shiwei Zhang, Yuxiang Yin, Wenjie Zhu, Ning Jiang, H. Guo, Danyan Li, Rong Yang, Shun Zhang, Tianhang Li
article en
Abstract
No abstract available for this paper.
Publication Tag
The Journal of Urology
Institutions
Sun Yat-sen University (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN), Zhongda Hospital Southeast University (CN), Nanjing Drum Tower Hospital (CN)